Role(s) in Healthcare Innovation:

Entrepreneur

Dave Hall

CEO and Co-Founder


Information Technology and Services, Greater Boston Area

About Me

Startup CEO and Advisor to growing companies looking to increase revenues and build brand awareness and get connected with key channels: *Kona DataSearch: Enterprise Search Architecture and Deep Learning to solve the business intelligence, data mining and artificial intelligence challenge in Salesforce. *Remio Consulting: a boutique Salesforce development partner offering Advanced Architecture, Integration and Data Forensics to tackle the toughest Salesforce environments. *GlucoSight: Disruptive, non-invasive diabetes technology to determine glucose levels. GlucoSight's "Diabetes as a Service" will drastically improve the diabetic's user experience. *Aquiva Labs: Application Development for Salesforce and the Force.com Community. Aquiva has built a true "Development as a Service" team to support your internal dev process.

I am looking for healthcare innovations:

You have not backed any projects. Lets change that!
Discover Projects

No project created yet. Lets change that!
Discover Projects

No comments on any project yet. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No project reviewed yet. Lets change that!
Discover Projects

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.